A genome‐wide association study of recipient genotype and medium‐term kidney allograft function

Abstract

Using a genome-wide approach, we have identified two associations with five-yr creatinine levels in renal transplant recipients treated with calcineurin inhibitors. Independent replication is now warranted to clarify the clinical significance of these results.